UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Elacestrant (RAD1901), a Selective Estrogen Receptor Degrader (SERD), Has Antitumor Activity in Multiple ER + Breast Cancer Patient-derived Xenograft Models

Clinical cancer research, 2017-08, Vol.23 (16), p.4793-4804

2017

Volltextzugriff (PDF)

Elacestrant (RAD1901) exhibits anti-tumor activity in multiple ER+ breast cancer models resistant to CDK4/6 inhibitors

Breast cancer research : BCR, 2019-12, Vol.21 (1), p.146-146, Article 146

2019

Volltextzugriff (PDF)

Compensatory insulin receptor (IR) activation on inhibition of insulin-like growth factor-1 receptor (IGF-1R): rationale for cotargeting IGF-1R and IR in cancer

Molecular cancer therapeutics, 2010-10, Vol.9 (10), p.2652-2664

2010

Volltextzugriff (PDF)

Sequestration of Adenoviral Vector by Kupffer Cells Leads to a Nonlinear Dose Response of Transduction in Liver

Molecular therapy, 2001-01, Vol.3 (1), p.28-35

2001

Volltextzugriff (PDF)

Interferon-β Gene Therapy Inhibits Tumor Formation and Causes Regression of Established Tumors in Immune-Deficient Mice

Proceedings of the National Academy of Sciences - PNAS, 1998-11, Vol.95 (24), p.14411-14416

1998

Volltextzugriff (PDF)

Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients

Journal of cachexia, sarcopenia and muscle, 2015-12, Vol.6 (4), p.317-324

2015

Volltextzugriff (PDF)

Antibody-Mediated Blockade of Integrin αvβ6Inhibits Tumor Progression In vivo by a Transforming Growth Factor-β-Regulated Mechanism

Cancer research (Chicago, Ill.), 2008-01, Vol.68 (2), p.561-570

2008

Volltextzugriff (PDF)

Abstract 1441: Induction of cancer cachexia by inflammatory molecules in directed complementation tumor models

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.1441-1441

2014

Volltextzugriff (PDF)

Abstract 1153: Effective treatment of cancer associated cachexia by AV-380, a GDF15 inhibitory antibody

Cancer research (Chicago, Ill.), 2015-08, Vol.75 (15_Supplement), p.1153-1153

2015

Volltextzugriff (PDF)

Antibody-mediated blockade of integrin alpha v beta 6 inhibits tumor progression in vivo by a transforming growth factor-beta-regulated mechanism

Cancer research (Chicago, Ill.), 2008-01, Vol.68 (2), p.561-570

2008

Volltextzugriff (PDF)

Abstract 4650: From bench to bedside: are cytokines still relevant biomarkers for staging cancer cachexia

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.4650-4650

2013

Volltextzugriff (PDF)

Abstract 3504: Plasma growth differentiating factor-15 (GDF-15) and other inflammatory markers are associated with weight loss and poor prognosis in cancer patients

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.3504-3504

2013

Volltextzugriff (PDF)

Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients: GDF15 in cancer-related weight loss

Journal of cachexia, sarcopenia and muscle, 2015-12, Vol.6 (4), p.317-324

2015

Volltextzugriff (PDF)

Abstract 1631: Tumorigenicity of IGF-1R and IR: Rationale for co-targeting IGF-1R and IR in cancer

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.1631-1631

2011

Volltextzugriff (PDF)

Abstract 646: Identification of FURIN as a tumor maintenance gene in solid tumors by in vivo Retroviral Mutagenesis and Directed Complementation

Cancer research (Chicago, Ill.), 2010-04, Vol.70 (8_Supplement), p.646-646

2010

Volltextzugriff (PDF)

Abstract A233: Generation of in vitro and in vivo tumor models driven by insulin-like growth factor receptor (IGF1R) and their use in the development of OSI-906, a selective IGF1R inhibitor

Molecular cancer therapeutics, 2009-12, Vol.8 (12_Supplement), p.A233-A233

2009

Volltextzugriff (PDF)

Genetic code in evolution: switching species-specific aminoacylation with a peptide transplant

The EMBO journal, 1998-01, Vol.17 (1), p.297-305

1998

Volltextzugriff (PDF)

Cloning and Expression of a Gene Encoding an Integrin-Like Protein in Candida albicans

Proceedings of the National Academy of Sciences - PNAS, 1996-01, Vol.93 (1), p.357-361

1996

Volltextzugriff (PDF)

Antibody-Mediated Blockade of Integrin alpha sub(v) beta sub(6) Inhibits Tumor Progression In vivo by a Transforming Growth Factor- beta -Regulated Mechanism

Cancer research (Chicago, Ill.), 2008-01, Vol.68 (2), p.561-570

2008

Volltextzugriff (PDF)

Species-specific microhelix aminoacylation by a eukaryotic pathogen tRNA synthetase dependent on a single base pair

Biochemistry (Easton), 1995-10, Vol.34 (39), p.12489-12495

1995

Volltextzugriff (PDF)

Enhancement of astaxanthin production, recovery, and bio-accessibility in Haematococcus pluvialis through taurine-mediated inhibition of secondary cell wall formation under high light conditions

Bioresource technology, 2023-12, Vol.389, p.129802-129802, Article 129802

2023

Volltextzugriff (PDF)

Simultaneous determination of cysteine, ascorbic acid and uric acid by capillary electrophoresis with electrochemiluminescence

Journal of electroanalytical chemistry (Lausanne, Switzerland), 2012-06, Vol.674, p.65-70

2012

Volltextzugriff (PDF)

A Multi-Objective Optimization Method for Maritime Search and Rescue Resource Allocation: An Application to the South China Sea

Journal of marine science and engineering, 2024-01, Vol.12 (1), p.184

2024

Volltextzugriff (PDF)

Photocatalytic pure water splitting activities for ZnGa2O4 synthesized by various methods

Materials research bulletin, 2015-01, Vol.61, p.481-485

2015

Volltextzugriff (PDF)

Highly Conductive and Wettable PEDOT:PSS for Simple and Efficient Organic/c‐Si Planar Heterojunction Solar Cells

Solar RRL, 2020-04, Vol.4 (4), p.n/a

2020

Volltextzugriff (PDF)

1 – 25 von 26

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(26)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(26)

Sprache

Englisch
(26)

Erscheinungsjahr

n.n

Thema

Science & Technology
(12)
Humans
(7)
Animals
(6)
Life Sciences & Biomedicine
(6)
Mice
(5)
Female
(4)
Mice, Nude
(4)
Technology
(4)
Cell Line, Tumor
(3)
Interferon
(3)
Materials Science
(3)
Proteins
(3)
Species Specificity
(3)
Tumors
(3)
Xenograft Model Antitumor Assays
(3)
Adenoviruses
(2)
Amino Acyl-Trna Synthetases - Metabolism
(2)
Antibodies
(2)
Antineoplastic Agents
(2)
Base Sequence
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Elacestrant (RAD1901), a Selective Estrogen Receptor Degrader (SERD), Has Antitumor Activity in Multiple ER + Breast Cancer Patient-derived Xenograft Models

Elacestrant (RAD1901) exhibits anti-tumor activity in multiple ER+ breast cancer models resistant to CDK4/6 inhibitors

Compensatory insulin receptor (IR) activation on inhibition of insulin-like growth factor-1 receptor (IGF-1R): rationale for cotargeting IGF-1R and IR in cancer

Sequestration of Adenoviral Vector by Kupffer Cells Leads to a Nonlinear Dose Response of Transduction in Liver

Interferon-β Gene Therapy Inhibits Tumor Formation and Causes Regression of Established Tumors in Immune-Deficient Mice

Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients

Antibody-Mediated Blockade of Integrin αvβ6Inhibits Tumor Progression In vivo by a Transforming Growth Factor-β-Regulated Mechanism

Abstract 1441: Induction of cancer cachexia by inflammatory molecules in directed complementation tumor models

Abstract 1153: Effective treatment of cancer associated cachexia by AV-380, a GDF15 inhibitory antibody

Antibody-mediated blockade of integrin alpha v beta 6 inhibits tumor progression in vivo by a transforming growth factor-beta-regulated mechanism

Abstract 4650: From bench to bedside: are cytokines still relevant biomarkers for staging cancer cachexia

Abstract 3504: Plasma growth differentiating factor-15 (GDF-15) and other inflammatory markers are associated with weight loss and poor prognosis in cancer patients

Plasma growth differentiation factor 15 is associated with weight loss and mortality in cancer patients: GDF15 in cancer-related weight loss

Abstract 1631: Tumorigenicity of IGF-1R and IR: Rationale for co-targeting IGF-1R and IR in cancer

Abstract 646: Identification of FURIN as a tumor maintenance gene in solid tumors by in vivo Retroviral Mutagenesis and Directed Complementation

Abstract A233: Generation of in vitro and in vivo tumor models driven by insulin-like growth factor receptor (IGF1R) and their use in the development of OSI-906, a selective IGF1R inhibitor

Genetic code in evolution: switching species-specific aminoacylation with a peptide transplant

Cloning and Expression of a Gene Encoding an Integrin-Like Protein in Candida albicans

Antibody-Mediated Blockade of Integrin alpha sub(v) beta sub(6) Inhibits Tumor Progression In vivo by a Transforming Growth Factor- beta -Regulated Mechanism

Species-specific microhelix aminoacylation by a eukaryotic pathogen tRNA synthetase dependent on a single base pair

Enhancement of astaxanthin production, recovery, and bio-accessibility in Haematococcus pluvialis through taurine-mediated inhibition of secondary cell wall formation under high light conditions

Simultaneous determination of cysteine, ascorbic acid and uric acid by capillary electrophoresis with electrochemiluminescence

A Multi-Objective Optimization Method for Maritime Search and Rescue Resource Allocation: An Application to the South China Sea

Photocatalytic pure water splitting activities for ZnGa2O4 synthesized by various methods

Highly Conductive and Wettable PEDOT:PSS for Simple and Efficient Organic/c‐Si Planar Heterojunction Solar Cells

Suchergebnisse filtern